Mostrando 4 resultados de: 4
Filtros aplicados
Subtipo de publicación
Article(4)
Publisher
The Lancet(2)
BMJ Global Health(1)
European Heart Journal - Quality of Care and Clinical Outcomes(1)
Área temáticas
Enfermedades(3)
Problemas sociales y servicios a grupos(3)
Fisiología humana(2)
Farmacología y terapéutica(1)
Medicina y salud(1)
Área de conocimiento
Enfermedad cardiovascular(2)
Epidemiología(1)
Farmacología(1)
Género(1)
Inequidad económica(1)
Origen
scopus(4)
Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study
ArticleAbstract: Background: There is a paucity of data on the prevalence of risk factors and their associations withPalabras claves:Autores:Abdul-Razak S., Alhabib K.F., Anand S.S., Avezum A.J., Breet Y., Chifamba J., DIaz R., Gupta R., Hu B., Iqbal R., Ismail R., Kelishadi R., Khatib R., Lang X., Li S., Mohan V., Oguz A., Palileo-Villanueva L.M., PATRICIO LOPEZ -JARAMILLO, Pinnaka L.V.M., Poltyn-Zaradna K., R S.P., Rangarajan S., Rosengren A., Seron P., Sharief W.M., Teo K.K., Verghese S.T., Walli-Attaei M., Wielgosz A., Yeates K.E., Yusuf R., Yusuf S.Fuentes:googlescopusVariations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
ArticleAbstract: Background: Some studies, mainly from high-income countries (HICs), report that women receive less cPalabras claves:Autores:Alhabib K.F., Anand S.S., Bahonar A., Chifamba J., Chow C.K., Dans A.M., Davletov K., DIaz R., Didkowska J.A., Felix Camilo, Irazola V.E., Joseph P.G., Kaur M., Khatib R., Lanas F.T., Lear S.A., Liu X., Mańczuk M., Miranda J.J., Oguz A., Pérez-Mayorga M., Poirier P., Rangarajan S., Rosengren A., Rosnah I., Szuba A., Teo K.K., Tsolekile L.P., Varma R.P., Walli-Attaei M., Wei L., Yeates K.E., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusThe cost implications of a polypill for primary prevention in the TIPS-3 trial
ArticleAbstract: Aims The International Polycap Study 3 (TIPS-3) trial demonstrated that a polypill containing cholesPalabras claves:Cardiovascular disease, cost analysis, Polypill, Primary PreventionAutores:Dans A.L., Gamra H., Gao P., Joseph P.G., Lamy A., Pais P., PATRICIO LOPEZ -JARAMILLO, Santoso A., Talukder S.H., Tong W., Walli-Attaei M., Xavier D., Yusuf S.Fuentes:googlescopusThe household economic burden of non-communicable diseases in 18 countries
ArticleAbstract: Background Non-communicable diseases (NCDs) are the leading cause of death globally. In 2014, the UnPalabras claves:Cardiovascular disease, DIABÉTES, Health economics, health insurance, health systemsAutores:Alhabib K.F., Avezum A.J., Calik K.B.T., Chifamba J., Choudhury T., Dagenais G.R., Dans A.M., Gupta R., Hanson K., Iqbal R., Kaur M., Kelishadi R., Khatib R., Kruger L., Kutty V.R., Lear S.A., Li W., Mckee M., Mohan V., Mony P.K., Murphy A., Orlandini A., Palafox B., PATRICIO LOPEZ -JARAMILLO, Powell-Jackson T., Rangarajan S., Rosengren A., Rosnah I., Seron P., Teo K.K., Tse L.A., Tsolekile L.P., Walli-Attaei M., Wang Y., Wielgosz A., Yan R., Yeates K.E., Yusoff K., Yusuf S., Zatońska K.Fuentes:googlescopus